SE9301911D0 - New peptide derivatives - Google Patents

New peptide derivatives

Info

Publication number
SE9301911D0
SE9301911D0 SE19939301911A SE9301911A SE9301911D0 SE 9301911 D0 SE9301911 D0 SE 9301911D0 SE 19939301911 A SE19939301911 A SE 19939301911A SE 9301911 A SE9301911 A SE 9301911A SE 9301911 D0 SE9301911 D0 SE 9301911D0
Authority
SE
Sweden
Prior art keywords
peptide derivatives
new peptide
structural fragment
iie
iid
Prior art date
Application number
SE19939301911A
Other languages
English (en)
Inventor
Thomas *Antonsson Karl
Elvy *Bylund Ruth
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Priority to SE19939301911A priority Critical patent/SE9301911D0/sv
Publication of SE9301911D0 publication Critical patent/SE9301911D0/sv
Priority to EP94917871A priority patent/EP0701567A1/en
Priority to AU69408/94A priority patent/AU685465B2/en
Priority to PCT/SE1994/000534 priority patent/WO1994029335A1/en
Priority to JP7501664A priority patent/JPH08511017A/ja

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE19939301911A 1993-06-03 1993-06-03 New peptide derivatives SE9301911D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE19939301911A SE9301911D0 (sv) 1993-06-03 1993-06-03 New peptide derivatives
EP94917871A EP0701567A1 (en) 1993-06-03 1994-06-02 New peptides derivatives
AU69408/94A AU685465B2 (en) 1993-06-03 1994-06-02 New peptides derivatives
PCT/SE1994/000534 WO1994029335A1 (en) 1993-06-03 1994-06-02 New peptides derivatives
JP7501664A JPH08511017A (ja) 1993-06-03 1994-06-02 新規なペプチド誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939301911A SE9301911D0 (sv) 1993-06-03 1993-06-03 New peptide derivatives

Publications (1)

Publication Number Publication Date
SE9301911D0 true SE9301911D0 (sv) 1993-06-03

Family

ID=20390161

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939301911A SE9301911D0 (sv) 1993-06-03 1993-06-03 New peptide derivatives

Country Status (5)

Country Link
EP (1) EP0701567A1 (sv)
JP (1) JPH08511017A (sv)
AU (1) AU685465B2 (sv)
SE (1) SE9301911D0 (sv)
WO (1) WO1994029335A1 (sv)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5614198A (en) * 1995-07-25 1997-03-25 The Trustees Of The University Of Pennsylvania Bowman-Birk Inhibitor compositions for treatment of inflammatory disease
US5965532A (en) * 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6100234A (en) 1997-05-07 2000-08-08 Tufts University Treatment of HIV
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
CA2304206A1 (en) 1997-09-29 1999-04-08 Point Therapeutics, Inc. Stimulation of hematopoietic cells in vitro
AU770319C (en) 1998-05-04 2004-11-25 Point Therapeutics, Inc. Hematopoietic stimulation
WO1999062914A1 (en) 1998-06-05 1999-12-09 Point Therapeutics, Inc. Cyclic boroproline compounds
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
GB0205527D0 (en) * 2002-03-08 2002-04-24 Ferring Bv Inhibitors
EP1736465A4 (en) 2004-03-31 2009-06-17 Ajinomoto Kk ANILINE DERIVATIVES
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
GB2494851A (en) 2011-07-07 2013-03-27 Kalvista Pharmaceuticals Ltd Plasma kallikrein inhibitors
GB201212081D0 (en) 2012-07-06 2012-08-22 Kalvista Pharmaceuticals Ltd New polymorph
GB201300304D0 (en) 2013-01-08 2013-02-20 Kalvista Pharmaceuticals Ltd Benzylamine derivatives
PH12015501492A1 (en) 2013-01-08 2015-09-28 Kalvista Pharmaceuticals Ltd Benzylamine derivatives
GB2510407A (en) * 2013-02-04 2014-08-06 Kalvista Pharmaceuticals Ltd Aqueous suspensions of kallikrein inhibitors for parenteral administration
MX363689B (es) 2013-05-23 2019-03-29 Kalvista Pharmaceuticals Ltd Derivados de heterociclicos.
TWI636047B (zh) 2013-08-14 2018-09-21 英商卡爾維斯塔製藥有限公司 雜環衍生物
CN105683179B (zh) 2013-08-14 2018-10-26 卡尔维斯塔制药有限公司 血浆激肽释放酶的抑制剂
GB2517908A (en) 2013-08-14 2015-03-11 Kalvista Pharmaceuticals Ltd Bicyclic inhibitors
GB201421088D0 (en) 2014-11-27 2015-01-14 Kalvista Pharmaceuticals Ltd New enzyme inhibitors
GB201421083D0 (en) 2014-11-27 2015-01-14 Kalvista Pharmaceuticals Ltd Enzyme inhibitors
GB201421085D0 (en) 2014-11-27 2015-01-14 Kalvista Pharmaceuticals Ltd New enzyme inhibitors
JP6884801B2 (ja) 2016-05-31 2021-06-09 カルビスタ・ファーマシューティカルズ・リミテッド 血漿カリクレインインヒビターとしてのピラゾール誘導体
GB201609607D0 (en) 2016-06-01 2016-07-13 Kalvista Pharmaceuticals Ltd Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts
GB201609603D0 (en) 2016-06-01 2016-07-13 Kalvista Pharmaceuticals Ltd Polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide
IL274557B1 (en) 2017-11-29 2024-05-01 Kalvista Pharmaceuticals Ltd Dosage forms containing a plasma kallikrein inhibitor
GB201719881D0 (en) 2017-11-29 2018-01-10 Kalvista Pharmaceuticals Ltd Solid forms of plasma kallikrein inhibitor and salts thereof
US11584714B2 (en) 2018-05-29 2023-02-21 Omeros Corporation MASP-2 inhibitors and methods of use
GB201910116D0 (en) 2019-07-15 2019-08-28 Kalvista Pharmaceuticals Ltd Treatments of hereditary angioedema
GB201910125D0 (en) 2019-07-15 2019-08-28 Kalvista Pharmaceuticals Ltd Treatments of angioedema
WO2021028645A1 (en) 2019-08-09 2021-02-18 Kalvista Pharmaceuticals Limited Plasma kallikrein inhibitors
JP2023504543A (ja) 2019-12-04 2023-02-03 オメロス コーポレーション Masp-2阻害剤および使用方法
GB2591730A (en) 2019-12-09 2021-08-11 Kalvista Pharmaceuticals Ltd New polymorphs
GB201918994D0 (en) 2019-12-20 2020-02-05 Kalvista Pharmaceuticals Ltd Treatments of diabetic macular edema and impaired visual acuity
TW202228686A (zh) 2020-10-15 2022-08-01 英商卡爾維斯塔製藥有限公司 血管性水腫之治療
WO2022084693A1 (en) 2020-10-23 2022-04-28 Kalvista Pharmaceuticals Limited Treatments of angioedema
WO2022172006A1 (en) 2021-02-09 2022-08-18 Kalvista Pharmaceuticals Limited Treatments of hereditary angioedema
WO2023002219A1 (en) 2021-07-23 2023-01-26 Kalvista Pharmaceuticals Limited Treatments of hereditary angioedema
EP4288036A1 (en) 2022-04-27 2023-12-13 Kalvista Pharmaceuticals Limited Formulations of a plasma kallikrein inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
GB9019558D0 (en) * 1990-09-07 1990-10-24 Szelke Michael Enzyme inhibitors

Also Published As

Publication number Publication date
JPH08511017A (ja) 1996-11-19
AU685465B2 (en) 1998-01-22
AU6940894A (en) 1995-01-03
WO1994029335A1 (en) 1994-12-22
EP0701567A1 (en) 1996-03-20

Similar Documents

Publication Publication Date Title
SE9301911D0 (sv) New peptide derivatives
TW334418B (en) Stilbene derivatives and pharmaceutical compositions
TR199902593T2 (xx) �kame edilmi� fenil t�revleri, bunlar�n haz�rlanmas� ve kullan�m�.
ES2172069T3 (es) Derivado tetrapeptidico.
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
IL126610A0 (en) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3- one derivatives as factor xa inhibitors
BR8906791A (pt) Composicao inseticida; derivado de guanidina e processo para sua preparacao
ATE200783T1 (de) Neuartige peptidderivate
AU8772691A (en) New compounds
TW336939B (en) Lipopeptide derivatives, a process for their preparation and their use
CA2118812A1 (en) 5-ht4 receptor antagonists
CA2020838A1 (en) Hemoregulatory peptides
EP0667163A4 (en) POWDER ALLOWING THE NASAL ADMINISTRATION OF A PEPTIDE OR PROTEIN MEDICINAL PRODUCT
DE68912438D1 (de) Antifungale Antibiotika.
DE69703878D1 (de) Guanidinium-verbindungen, pharmazeutische präparate davon und ihre verwendungen
RU94014631A (ru) Производные 4-хиномиодигидропиридина, смесь их изомеров или отдельные изомеры и их соли
DE69423339D1 (de) Epoxycyclohexendionderivat
ATE282608T1 (de) Chinoxalindionen
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
ATE104315T1 (de) Peptid-derivate und wirkstoffe gegen dementia.
FI930092A (fi) Indanopyrrolidinkarbamater
IT1251202B (it) 6-amminochinoloni, sintesi ed impiego come antibatterici
DK158729C (da) N-(3-trifluormethylphenyl)-n'-propargylpiperazin, farmaceutiske praeparater, der indeholder det, dets anvendelse, samt en fremgangsmaade til fremstilling af et farmaceutisk praeparat
EA199900688A1 (ru) Хиноксалиндионы